4-Hydroxyphenylretinamide ≥97% (by TLC)
Supplier: Enzo Life Sciences
|
Danger
|
Synonyms:
(2E,4E,6E,8E)-N-(4-Hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenamide
, Fenretinide
, 4-HPR
, all-trans-N-(4-Hydroxyphenyl)retinamide
, N-(4-Hydroxyphenyl)-all- trans retinamide
, Retinoic Acid p-Hydroxyanilide
Retinoic acid receptor ligand.
An analog of all trans retinoic acid that shows antiproliferative activity on cultured human breast cancer cells. Highly selective activator of retinoid receptors. Induces apoptosis in malignant hemopoietic cell lines.
Soluble in DMSO (25 mg/mL) or 100% ethanol (25 mg/mL).
Formula:
C₂₆H₃₃NO₂ MW: 391.56 g/mol |
MDL Number:
MFCD00792674 CAS Number: 65646-68-6 |
Specification Test Results
Source | Synthetic |
Purity | ≥97% (TLC) |
Appearance | Orange solid |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...